Galmed Pharmaceuticals declined 2% to close at $3.42 on March 18 after the clinical-stage biopharmaceutical company posted a wider-than-feared loss in the fourth …
Is a pause to the stock market’s continued surge finally in the cards? The talk has turned to rising interest rates and the …
On Wall Street, some things never change. Public health crisis or not, the fact of the matter remains that healthcare stocks are the …
Galmed Pharmaceuticals (NASDAQ:GLMD) shares are soaring nearly 20% in after-hours trading Wednesday, as the drug maker gets a vote of confidence from Cantor …
It’s a big day for Galmed Pharmaceuticals (NASDAQ:GLMD). The drug maker released positive phase Phase 2b data for Aramchol in NASH that had many, even …
Investors love biotech stocks for the lottery ticket-like returns they can offer if a company strikes medical gold. Case in point: Galmed Pharmaceuticals …
Did an iceberg just wallop into Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock? This biotech company’s shares are plunging at breakneck speed of almost 53%.
Tobira Therapeutics Inc (NASDAQ:TBRA) shares are on fire this Tuesday, jumping over 700%, following the news that the company entered into a definitive agreement …
In a research note issued today, Maxim Group analyst Jason Kolbert assigned a Buy rating on shares of Galmed Pharmaceuticals (NASDAQ:GLMD) with a $24 price target, …
